期刊
CELL CYCLE
卷 7, 期 21, 页码 3417-3427出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.7.21.6982
关键词
p53; tubulin polymerization; small molecule screen
类别
资金
- Tenovus Scotland
- Breast Cancer Research (Scotland)
- Medical Research Council
- Royal Society
- CRUK
A robust p53 cell-based assay that exploits p53's function as a transcription factor was used to screen a small molecule library and identify bioactive small molecules with potential antitumor activity. Unexpectedly, the majority of the highest ranking hit compounds from this screen arrest cells in mitosis and most of them impair polymerization of tubulin in cells and in vitro. One of these novel compounds, JJ78:1, was subjected to structure-activity relationship studies and optimized leading to the identification of JJ78:12. This molecule is significantly more potent than the original hit JJ78: 1, as it is active in cells at two-digit nanomolar concentrations and shows clear antitumor activity in a mouse xenograft model as a single agent. The effects of nocodazole, a well established tubulin poison, and JJ78: 12 on p53 levels are remarkably similar, supporting that tubulin depolymerization is the main mechanism by which JJ78: 12 treatment leads to p53 activation in cells. In summary, these results identify JJ78: 12 as a potential cancer therapeutic, demonstrate that screening for activators of p53 in a cell-based assay is an effective way to identify inhibitors of mitosis progression and highlights p53's sensitivity to alterations during mitosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据